메뉴 건너뛰기
Liver International
Volumn 29, Issue 6, 2009, Pages 950-951
Early development of clevudine resistance during clevudine therapy in a patient with chronic hepatitis B who received prior lamivudine therapy
Author keywords

[No Author keywords available]
Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CLEVUDINE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;
EID: 67049143568     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01967.x     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 36348953975 scopus 로고    scopus 로고
    • Clevudine is highly efficacious in hepatits B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression
    • Yoo BC, Kim JH, Kim T-H, et al. Clevudine is highly efficacious in hepatits B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology 2007; 46: 1041-8.
    • (2007) Hepatology , vol.46 , pp. 1041-1048
    • Yoo, B.C.1    Kim, J.H.2    Kim, T.-H.3
  • 2
    • 34248668494 scopus 로고    scopus 로고
    • Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B
    • Yoo BC, Kim JH, Chung Y-H, et al. Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology 2007; 45: 1172-8.
    • (2007) Hepatology , vol.45 , pp. 1172-1178
    • Yoo, B.C.1    Kim, J.H.2    Chung, Y.-H.3
  • 3
    • 61549138163 scopus 로고    scopus 로고
    • Management of chronic hepatitis B
    • Lee KS, Kim DJ. Management of chronic hepatitis B. Korean J Hepatol 2007; 13: 447-88.
    • (2007) Korean J Hepatol , vol.13 , pp. 447-488
    • Lee, K.S.1    Kim, D.J.2
  • 4
    • 3042782464 scopus 로고    scopus 로고
    • A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
    • Marcellin P, Mommeja-Marin H, Sacks SL, et al. A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B. Hepatology 2004; 40: 140-8.
    • (2004) Hepatology , vol.40 , pp. 140-148
    • Marcellin, P.1    Mommeja-Marin, H.2    Sacks, S.L.3
  • 5
    • 67049137129 scopus 로고    scopus 로고
    • Clevudine was superior to lamivudine in the patients with HBeAg (+) chronic hepatitis B
    • Lau GK, Leung N, Hui CK, et al. Clevudine was superior to lamivudine in the patients with HBeAg (+) chronic hepatitis B. Hepatol Int 2008; 2(Suppl. 3): A89.
    • (2008) Hepatol Int , vol.2 , Issue.SUPPL. 3
    • Lau, G.K.1    Leung, N.2    Hui, C.K.3
  • 6
    • 33744531146 scopus 로고    scopus 로고
    • Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B
    • Sherman M, Yurdaydin C, Sollano J, et al. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology 2006; 130: 2039-49.
    • (2006) Gastroenterology , vol.130 , pp. 2039-2049
    • Sherman, M.1    Yurdaydin, C.2    Sollano, J.3
  • 7
    • 33847709539 scopus 로고    scopus 로고
    • Adding-on versus switching-to adefovir therapy in Lamivudine-resistant HBeAg-negative chronic hepatitis B
    • Rapti I, Dimou E, Mitsoula P, Hadziyannis SJ. Adding-on versus switching-to adefovir therapy in Lamivudine-resistant HBeAg-negative chronic hepatitis B. Hepatology 2007; 45: 307-13.
    • (2007) Hepatology , vol.45 , pp. 307-313
    • Rapti, I.1    Dimou, E.2    Mitsoula, P.3    Hadziyannis, S.J.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.